et al.. X-ray structural studies of the entire extra-cellular region of the Ser/Thr kinase PrkC from Staphylococcus aureus.
INTRODUCTION
Signal transduction through reversible protein phosphorylation is a key regulatory mechanism of both prokaryotes and eukaryotes. Phosphorylation frequently occurs in response to environmental signals and is mediated by specific protein kinases. Generally, phosphorylation is coupled to dephosphorylation reactions catalysed by protein phosphatases. Eukaryotic-type serine/threonine kinases are expressed in many prokaryotes including a broad range of pathogens. The first reported eukaryotic-type serine/threonine kinase, Pkn1 from Myxococcus xanthus, was found to be required for normal bacterial development [1] . The advance of genome sequencing has prompted the identification of similar kinases in many bacteria. These kinases are now known to regulate various cellular functions, such as biofilm formation [2] , cell wall biosynthesis [3, 4] , cell division [3] , sporulation [2, 5] , stress response [6] .
Recent studies reported that the eukaryotic-type serine/threonine kinase PrkC from Bacillus subtilis is also involved in bacterial exit from dormancy [7, 8] . Under conditions of nutritional limitation, B. subtilis produces dormant spores, which are resistant to harsh environmental conditions and can survive in a dormant state for years [7, [9] [10] [11] . The process of resuscitation is called, in these sporulating bacteria, germination [7, 8] . Generally, growing bacteria release muropeptides in the surrounding environment, due to cell wall peptidoglycan remodelling associated to cell growth and division [12, 13] . Therefore, the presence of muropeptides in the close environment of dormant spores is a clear signal that conditions are optimal for growth. Consistently, Shah el al. reported that m-Dpm-containing muropeptides are powerful germinants of B. subtilis spores [7] . Notably, other authors have independently proposed the idea that the activating ligand of PrkC could be a component or a degradation product of the cell wall peptidoglycan [6] . These authors also showed that, once activated, PrkC is able to phosphorylate the small ribosome-associated GTPase CpgA, the translation factor EF-Tu, and a component of the bacterial stressosome, denoted as YezB [6] . On the other hand, the possible involvement of the elongation factor EF-G as a substrate of PrkC is controversial [6, 7, 14] .
A close homologue of PrkC exists in Staphylococcus aureus, a significant human pathogen that causes a number of infections ranging from skin infections to toxic shock syndrome, osteomyelitis and myocarditis [15, 16] . PrkC kinase from S. aureus is predicted to be a membrane protein, similar to its homologue from B. subtilis [2] . The two kinases present the same domain organisations, with an intracellular serine/threonine kinase domain, a transmembrane region, and an extra-cellular portion that contains three domains denoted as PASTA (Penicillin binding Associated and Serine/Threonine kinase Associated domains). Such domains also exist in penicillin binding proteins [17] . The crystal structure of the penicillin binding protein PBP2x from S. peumoniae, which contains two C-terminal PASTA domains, was solved in complex with cefuroxime, a βlactam antibiotic mimicking the unlinked peptidoglycan [18, 19] . In this structure, cefuxomine binds one PASTA domain [18, 19] , a finding which has suggested that PASTA domains of PrkC can bind muropeptides [7] . According to Shah et al., B. subtilis spores germinate in response to m-Dpm containing muropeptide, which constitute B. subtilis cell wall, but not in response to L-Lys containing muropeptide [7] . Moreover, when the PrkC from B. subtilis is substituted by PrkC from S. aureus, which is characterised by L-Lys containing cell walls, germination is observed both in response to m-Dpm and L-Lys containing muropeptide. This finding has shown that the source of PrkC determines the bacterial ability to respond to muropeptides and has suggested that PrkC extracellular domains exhibit specificity of muropeptide binding [7] . Despite these hypotheses, structural results are still needed to help the understanding of the function of extracellular domains.
To get insight into the mechanism of regulation of PrkC activity, mediated by the kinase extracellular domains, we undertook a structural study of the extra-cellular portion of PrkC from S. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
aureus (EC-PrkC, residues 378-664, 33 kDa). The increase of S. aureus strains resistant methicillin, a β-lactam antibiotic of the penicillin class, makes infections particularly troublesome and difficult to treat in hospitals, where patients are at greater risk of infection than the general public. The present structural study provides a valuable template for the rational design of new anti-bacterial molecular entities able to interfere with cellular processes regulated by PrkC.
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The extra-cellular region of PrkC has the shape of a golf-stick
The crystal structure of EC-PrkC revealed that the extra-cellular region of PrkC consists of four consecutive domains. The four domains are arranged sequentially in a golf-stick shape, such that only neighbouring domains interact with each other ( Figure 1B ). Three of the four domains are, as predicted, PASTA domains ( Figure 1A ). The structure shows that the three PASTA domains display a linear and regular organisation. Indeed, each domain exhibits a twofold symmetry with respect to its neighbouring domains ( Figure 1B ). In this organisation, the sole α-helix of each domain is alternatively located on the two sides of the golf-stick ( Figure 1B) . Interestingly, the structure reveals the existence of a fourth domain, at the C-terminal end of the molecule, not predicted by searches in the PFAM database [21] . Furthermore, sequence analyses against the Protein Data Bank do not identify any significant homolog for this domain.
Three predicted PASTA
This work provides the highest resolution study of PASTA domains, which are arranged in βαββββ motifs ( Figure 1B ,D). Despite a moderate sequence identity between EC-PrkC PASTA domains (from 21 to 27%, Table 2 ), the structures of these domains are well conserved. PASTA domains are constituents of the penicillin-binding PBP2x protein from S. pneumoniae [18] .
The crystal structure of PBP2x shows that its two PASTA domains form a compact structure with a pronounced inter-domain bending ( Figure 2 ). In this arrangement, each PASTA domain is involved in interactions with both the other PASTA domain and with the dimerisation and transpeptidase domains of PBP2x [18] . Differently, in the structure of EC-PrkC, the three PASTA domains are linearly arranged, with a limited number of inter-domain interactions. This finding suggests a high flexibility of the PrkC extra-cellular region. The structural comparison of PrkC PASTA domains with those of PBP2x shows a significant conservation of the PASTA fold, despite the low sequence identities, ranging from 5 to 28%, between domains ( Table 2 ). All secondary structure elements are conserved, although β-strands β4 and β5 do not appear in lower resolution PBP2x structures [22] . Despite an overall conservation of the fold, however, EC-PrkC PASTA domains present a six-residue insertion between β-strands β2 and β3 (YSDKYP, YNNQAP, YSDDID for PASTA 1, 2, and 3, respectively). Furthermore, a Ser-X-Gly motif, which does not exist in PBP2x, occurs at the C-terminal end of each PASTA domain. This sequence motif is conserved in many homologous bacterial proteins ( Figure S1 ). In each PASTA domain of EC-PrkC crystal structure, the serine side chain (Ser508 in PASTA2, Figure 2B ) of the Ser-X-Gly motif establishes a hydrogen bond with the backbone nitrogen of glycine (Gly510 in PASTA2) and with the carbonyl oxygen of a neighbouring residue (Ala480 in PASTA2) (Figure2B). These interactions may play a role in keeping a linear arrangement of PASTA domains. Conversely, a contribution to compact head-to-tail arrangement of PBP2x PASTA domains likely comes from their tertiary structure interactions with the rest of the protein structure ( Figure 2C ).
While this work was in preparation, the solution NMR structure of three overlapping sequences of PknB from M. tuberculosis, each embedding two PASTA domains, and the small-angle X-ray scattering study of the entire extra-cellular PknB portion (four PASTA domains) appeared [23] . Unlike PBP2x, the organisation of PASTA domains in the PknB structure is nearly linear [18, 23] . However, the overall RMSD calculated on Cα atoms after superposition of the three PASTA domains of EC-PrkC with those of PknB is as high as 9.5 Å (after superposition with PknB PASTA domains 2, 3 and 4) and 14.4 Å (after superposition with PknB PASTA domains 1, 2 and 3). This is mainly due to different arrangements of PASTA domains in PrkC and PknB ( Figure 3 ). Indeed, when single PASTA domains of EC-PrkC and PknB are superposed, a strong conservation of the domain fold is observed, even in cases when sequence identities are as low as 2-5% ( Table 2 ). Based on the observation that the two PASTA domains of PBP2x interact with each other ( Figure  2C ) [18] , the authors proposed that extra-cellular regions of PknB dimerise to activate the kinase, since only dimerisation would bring two PASTA domains in close contact [23] . However, it should be noted that the two PASTA domains of PBP2x are oriented in opposite directions ( Figure 2A ). Therefore, similar interactions would produce PknB dimers that would not allow the catalytic domains to interact (See Discussion).
PrkC C-terminal domain: an IG-like domain with a missing strand
The PrkC C-terminal domain (residues 577-664) exhibits an all-beta structure, which contains six βstrands arranged in a beta sandwich ( Figure 1C ). Sequence alignment analyses do not identify any structure in the PDB with significant sequence identity. However, a DALI [24] search of the Protein Data Bank (PDB) reveals that PrkC C-terminal domain structurally resembles a set of Immunoglobulin (IG) domains ( Table 3 ). The canonical structure of IG domains is formed by a three-stranded and a four-stranded β-sheet packed in β-sandwich arrangement [25] . Like canonical IG domains, PrkC IG domain (PrkC-IG) presents a hydrophobic core formed by both β-sheets, whereas residues pointing to the solvent are mainly hydrophilic; this results in alternating polar/unpolar sequence patterns of the β-strands. The topology of PrkC-IG can be classified as belonging to the s-type IG domains [25] . However, superposition of PrkC-IG to those identified with DALI (Table 3) shows that this domain misses the N-terminal strand (β-strand β* of the canonical IG domain, Figure 1C ). The sole identified protein that shares a similar feature is a type III domain of human fibronectin (PDB code 2h41, Table 3 ). In EC-PrkC, the N-terminal missing strand of PrkC-IG forms the linker with the PASTA3 domain ( Figure 1 ). Different from typical IG folds, where hydrophobic residues in the β* strand pack against the hydrophobic core, PrkC linker is highly hydrophilic. The volume occupied by hydrophobic residues of the β* strand in canonical IG domains is filled by bulky hydrophilic residues of β-strands β1 and β6 in EC-PrkC (data not shown). It is worth noting that IG domains similar to PrkC-IG are usually involved in cell-cell interactions and cell signalling [26] . Their adhesive properties are exploited both by bacterial [27, 28] and eukaryotic cells [29] and are typically due to the exposure of an anomalously large number of backbone β-strand hydrogen-bond donors and acceptors [30] . This is particularly true when IG folds are not complete and miss one β-strand (as in PrkC-IG, Figure 1C ), since this feature leads in extreme cases to IG polymerisation [31, 32] . These properties of PrkC-IG suggest that this domain may also play a role in peptidoglycan binding, in a fashion similar to the E. coli adhesin PapG with host glycolypids [33, 34] . Consistently, we noted that B. subtilis PrkC, which from shares similar properties in inducing bacterial sporulation, also contains a similar domain at its C-terminus. 
EC-PrkC oligomerisation state in the crystal state and in solution
Analysis of packing interactions between symmetry-related molecules of EC-PrkC crystal structure, using the software PISA [35] , evidenced no strong protein interfaces that would anticipate the existence of an oligomeric form of the protein. Given the importance of dimerisation in the activation of several kinases [26, 36] , we decided to check it using several techniques and experimental conditions. Gel filtration profiles of freshly purified EC-PrkC showed the existence of a species with molecular weight of about 66 kDa, compatible with a dimeric arrangement of the protein ( Figure S2 ). However, estimates of molecular weights by gel filtration depend on the protein shape and abnormal values are calculated for non-globular elongated molecules. Therefore, we used analytical size-exclusion chromatography (SEC), coupled with multiangle light scattering (MALS). MALS is a powerful tool to characterise the weight average molar mass (Mw) of compounds showing anomalous elution profiles in SEC. The on-line measurement of the intensity of the Rayleigh scattering as a function of the angle as well as the differential refractive index of the eluting peak in SEC was used to determine Mw. This analysis produced an Mw value of 31060 ±620 Da, which corresponds to a monomeric organisation of the molecule (Figure 4 ). In parallel, SEC-MALS experiments were carried out after overnight incubation of EC-PrkC with a mixture blend of natural muropeptides (Table 4 ). Results, which provided an Mw value of 31120 ± 311 Da, clearly showed that the protein retains its monomeric state also in the presence of a large excess of muropeptides ( Figure 4 ). Furthermore, to check if the molecular size distribution of EC-PrkC changes at increasing protein concentrations, we also performed Dynamic Light Scattering (DLS). This analysis was carried out at 25 °C using protein concentrations ranging from 1.0 to 6.0 mg/mL. In all conditions, a population of 2.8 ± 0.3 nm hydrodynamic radii (Rh) particles dominated and no significant variations of Rh values were observed as a function of concentration. Similarly, we measured the molecule Rh after its incubation with a 4-molar excess of natural muropeptides mixture ( Table 4) . As a result, we observed no significant variation of Rh. Therefore, high concentrations do not induce EC-PrkC dimerisation, also after incubation with muropeptides.
The possible formation of a complex deriving from self-recognition and the effect of muropeptides on this process were also evaluated using Surface Plasmon Resonance. Real Time binding assays were performed on a Biacore 3000 Surface Plasmon Resonance (SPR) instrument. EC-PrkC was immobilised using two different methods to ensure different experimental conditions and protein orientations on the chip: on a CM5 sensor chip by covalent EDC-NHS amine coupling and on an NTA (nitrilotriacetic acid) sensor chip, which immobilises the protein N-terminal His-tag on NTAchelated nickel of the chip. Furthermore, to investigate the effect of the ligand concentration on potential protein-protein interactions, we used two immobilisation levels (See Methods).
In both experiments, EC-PrkC was injected as analyte at concentrations ranging from 1.0 to 100 µM. The possible effect of muropeptides on protein-protein interaction was evaluated by injecting EC-PrkC after pre-incubation with the muropeptides mixture (Table 4 ) from 0 to 100 equivalents. As a result, no significant RU variation was observed in all SPR assays ( Figure S3 ). These results confirmed those obtained by SEC-MALS and DLS, that EC-PrkC has no tendency to self-aggregate and that muropeptides do not induce EC-PrkC dimerisation.
DISCUSSION
We present here the x-ray structure characterisation of the entire extra-cellular region of the Ser/Thr kinase PrkC from S. aureus, EC-PrkC. This kinase has been shown to signal peptidoglycan-induced revival of B. subtilis from dormancy, similar to B. subtilis endogenous PrkC [7] . The mechanism of peptidoglycan-induced activation of PrkC is, however, so far unknown. We show that of EC-PrkC adopts an elongated structure composed of four domains: three PASTA domains and a C-terminal domain, which was not predicted by searches in the PFAM database ( Figure 1A) . This latter domain, here denominated PrkC-IG, structurally resembles an Immunoglobulin (IG) fold, despite the low sequence identity with IG folds in the PDB. It is worth noting that PrkC from S. aureus and from B. subtilis share the same domain architecture and a reasonable sequence identity (about 27%). A domain similar to S. aureus PrkC-IG exists also in PrkC from B. subtilis, as suggested by the significantly high sequence identity (30%) between the C-terminal regions of the two homologous proteins. Therefore, it is not surprising that PrkC from the two bacteria induce similar responses in terms of germination of B. subtilis spores [7] .
The kinase domain of PrkC from S. aureus is homologous to that of the serine/threonine kinase PknB from M. tuberculosis (37% sequence identity). Similar to PknB [37] and to PrkC from B. subtilis [5] , the kinase domain of PrkC from S. aureus undergoes auto-phosphorylation [38] . Furthermore, the x-ray structure of the kinase domain of PknB suggests a model in which a structural and functionally asymmetric "front-to-front" association occurs. This dimerisation mode leads to the phosphorylation of serine and threonine residues located in the kinase activation loop [37] . Therefore, the most obvious mechanism to explain the muropeptide-driven activation of PrkC involves the muropeptide-induced dimerisation of the PrkC extra-cellular region that leads to the formation of the asymmetric, active, PrkC dimer.
Dimerisation is a typical event that activates kinases, since it permits auto-phosphorylation. However, the structural basis of this phenomenon may be different. Indeed, dimerisation can either be intrinsic, although stabilised by the activating ligand, or entirely induced by the activating ligand [26] . Our data demonstrate that PrkC extra-cellular region displays no intrinsic tendency to dimerise (Figure 4 ) and that the sole muropeptide fails to induce dimerisation even in the presence of a large muropeptide excess (Figures 4 and S3 ). It is worth noting that the extra-cellular region and, to a smaller extent, the trans-membrane region of PrkC from B. subtilis are able to form dimers in vivo [2] . Therefore, our data point to a more complex dimerisation mechanism, which may require the contribution of the trans-membrane domain [2] and may be only indirectly modulated by muropeptides. Furthermore, the dimerisation of the extra-cellular PrkC observed in vivo [2] may involve of a third molecule, yet unknown, in a fashion similar to that observed for the fibroblast growth factor receptor (FGFR) [39] . Indeed, dimerisation of FGFR involves three IG-like domains (domains D1-D3) and requires the simultaneous participation of both a fibroblast growth factor receptor (FGF) and heparin, through the formation of a ternary complex [26, 39] . It cannot be excluded, however, as previously observed for other kinase receptors [40] , that the binding of the sole muropeptide molecule is not sufficient induce dimerisation, but it stabilises a conformation of the extra-cellular region that favours the dimerisation of the entire molecule. Finally, our work provides a highresolution structure of the extra-cellular, and therefore accessible to drugs, region of PrkC. As such, they will be precious to r aimed at the development of novel anti-bacterial molecular entities able to interfere with processes involving PrkC. 
EXPERIMENTAL PROCEDURES Protein expression and purification. The plasmidic construct corresponding to the extra-cellular
PrkC of S. aureus (EC-PrkC, residues 378-664) has been prepared as previously described by Dworkin et al. [7] . The overexpression of EC-PrkC , containing an N-terminal histidine tag (His 6 ) was carried using E. coli DH5 cells (Invitrogen), as described [20] . Purification was performed by affinity chromatography, using a 5-mL Ni-NTA column (GEHelthcare). A further purification step included gel filtration, on a Superdex 200 column (GeHelthcare), equilibrated in 150 mM NaCl, 20 mM TrisHCl buffer at pH 8.0 and 5% (v/v) glycerol. The protein, which eluted in a single peak, was concentrated using a centrifugal filter device (Millipore), and the concentration was determined by Bradford protein assay (Biorad). Fresh concentrated protein at 10 mg mL -1 , was used for crystallisation experiments. Crystallisation, data collection and processing. Crystallisation trials were performed at 293 K using the hanging-drop vapor-diffusion method. Preliminary crystallisation conditions were set up using a robot station for high throughput crystallisation screening (Hamilton STARlet NanoJet 8+1) and commercially available sparse-matrix kits (Crystal Screen kits I and II, Hampton Research, Index). Optimisation of the crystallisation conditions was performed manually both using the vapordiffusion and the macro-seeding technique. Lutetium chloride derivative crystals were prepared by soaking a native crystal in a solution containing 1-3 mM lutetium chloride, 25% (w/v) MPEG2000, 160 mM ammonium sulphate, 60 mM sodium acetate trihydrate buffer for 3 hours at pH 4.6. A Multi-wavelength Anomalous Diffraction experiment (MAD) was carried out on a crystal derivatised with 2mM LuCl 3 at the X12 synchrotron beam line, DORIS storage ring, DESY (Hamburg, Germany), at 100 K. Cryoprotection of the crystals was achieved by a fast soaking in a solution containing glycerol to a final concentration of 10% (v/v). These data, extending to 3.0 Å resolution, allowed us to build a part of the molecule [20] . Derivatisation by overnight soaking in a solution containing 2mM Europium chloride provided higher resolution x-ray data, at 2.2 Å (Table  1) . Data collection was performed in-house at 100K using a Rigaku Micromax 007 HF generator producing Cu K radiation and equipped with a Saturn944 CCD detector. The data sets were scaled and merged using HKL2000 program package [41] (Table 1) . Structure determination. Initial phasing was performed on MAD x-ray data using the Auto-Rickshaw platform using the anomalous signal from the Lu3+ ions [42] . Better phasing was achieved using in-house Single Anomalous Dispersion data, collected on a crystal soaked overnight in a solution containing 2mM Europium chloride. These data provided structure factors phases to 2.2 Å resolution. Both SHELXD [43] and SOLVE identified five Europium ions. Phases, improved by phase extension and density modification by RESOLVE [44] and wARP [45] allowed us to trace nearly the entire molecule structure. Crystallographic refinement was carried out against 95% of the measured data using the CCP4 program suite [46] . The remaining 5% of the observed data, which was randomly selected, was used in Rfree calculations to monitor the progress of refinement. Structures were validated using the program PROCHECK [47] . Bioinformatic analysis. A set of tools was used to analyse the structural characteristics of PrkC. The database PFAM was searched to assign the domain organisation of the enzyme. BLAST searches were performed to look for possible structures with significant sequence identity. Transmembrane regions were searched using TMPRED and TMHMM [48, 49] . of natural muropeptides at room temperature. The protein-muropeptide mixture was then analysed by SEC-MALS in the same conditions used for the protein alone. In batch mode, samples were prepared at room temperature in 50 mM Tris-HCl, 150 mM NaCl buffer, pH 8.0. A stock solution of EC-PrkC was filtered through a 0.02 μm Millex syringe driven filter unit (Millipore, Bedford, MA). After a further measure of protein concentration, samples were prepared at concentrations ranging between 2.5 and 5.0 mg/ml. All measurements were registered in triplicates for 2 min acquisition time. The hydrodynamic radius (Rh) of the scattering molecules was derived, using the ASTRA software, from the diffusion coefficient from the Einstein-Stokes equation. Surface Plasmon Resonance experiments. Real Time binding assays were performed on a Biacore 3000 Surface Plasmon Resonance (SPR) instrument using two different sensor chips. Covalent immobilisation of EC-PrkC on a CM5 sensor chip was carried out with EDC-NHS amine coupling chemistry in 10 mM acetate buffer pH 4.0. In parallel, the N-terminal His-tag of EC-PrkC was immobilised on NTA sensor chip (flow rate 5 μL/min, injection time 7 min). In the covalent CM5 immobilisation, residual reactive groups were deactivated by treatment with 1 M ethanolamine hydrochloride, pH 8.5. The reference channel was prepared by activating with EDC/NHS and deactivating with ethanolamine. SPR experiments were performed with two different immobilisation levels: 2800 and 1000 RU in CM5 covalent immobilisation and 1063 and 364 RU in NTA His-tag capturing. A stock EC-PrkC solution was diluted in running buffer HBS (10 mM Hepes, 150 mM NaCl, 3 mM EDTA, pH 7.4) and injected as analyte (flow rate 20 μL/min, injection volume 90 L) at various concentrations in the range 1.0-100 µM. In parallel, EC-PrkC was pre-incubated with a mixture of natural muropeptides (Table 4 ), in the concentration range from 0 to 100 equivalents. As a control experiment, the muropeptide blend mixture ( Table 4 ) was also injected as analyte. Bacterial growth and purification of peptidoglycan. Dried cells of E. coli containing m-Dpmtype peptidoglycan were extracted as described elsewhere [50] . Briefly, cells were suspended in icecold water, added drop-wise to boiling 8% SDS and boiled for 30 min. After cooling down to room temperature, the SDS-insoluble material was collected by centrifugation. The pellets were washed several times with water until no SDS could be detected. High molecular weight glycogen and covalently bound lipoprotein were removed by treatment with -amylase and trypsin. Further sequential washes with 8 M LiCl, 0.1M EDTA and acetone were sequentially performed. Preparation of muropeptides, GC-MS, HPLC and LC-MS analyses. The isolated peptidoglycan was degraded with muramidase mutanolysin from Streptomyces globisporus ATCC21553 (Sigma-Aldrich) at 37°C overnight. The enzyme reaction was stopped by boiling (5 min), and insoluble contaminants were removed by centrifugation. The generated muropeptides were dissolved in 0.5 M sodium borate buffer, pH 9.0 and solid sodium borohydride was added immediately. After incubation for 30 min at room temperature, excess borohydride was destroyed with HCl 2M. Finally, the samples were adjusted to pH 3-4 with TFA. Reduced muropeptides were fractionated by reverse phase HPLC [50] . Briefly, the muropeptides were eluted with a linear gradient (run time 40 min) from 0 to 17.5% acetonitrile. Detection was by A 206 nm whereas identification was achieved by ESI+ MS and ESI-/MS spectra in 2% formic acid-methanol 1:1 v/v and water-methanol 1:1 v/v, respectively (Agilent 1100MSD) as described [51] . ACCESSION NUMBERS. Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 3py9. SUPPLEMENTAL INFORMATION. Supplemental Information includes three Supplemental figures and can be found with this article online at doi:xxx.
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